Found 18 matching trials
Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection PHASE2 This phase II trial studies how well donor cytomegalovirus-specific cytotox...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant NA RATIONALE: Tests that measure certain changes in blood in patients at high ...
Show More Location
Multiple Locations
Learn More & Join Trial
CMV-CTL for the Treatment of CMV Infection After HSCT PHASE4 Human cytomegalovirus (CMV) infection is a major cause of morbidity and mor...
Show More Location
Shanghai Jiao Tong University Affilated Shanghai General Hospital
Learn More & Join Trial
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant PHASE1 This phase I/II trial studies the safety and toxicity of post-transplant tr...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation PHASE2 The goal of this clinical research study is to learn if giving cytotoxic T ...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT PHASE1 Human cytomegalovirus (CMV) is a benign infectious agent in the normal host...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT EARLY_PHASE1 This trial studies the side effects and how well allogeneic cytomegalovirus...
Show More Location
Nationwide Children's Hospital
Learn More & Join Trial
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV PHASE1 This protocol is a phase I study. Patients may be eligible for an infusion ...
Show More Location
Medical College of Wisconsin
Learn More & Join Trial
T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant PHASE2 RATIONALE: An infusion of cytomegalovirus-specific T lymphocytes may preven...
Show More Location
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust
Learn More & Join Trial